NIH Study Examines How Pregnancy Affects Drugs for HIV and TB in People Living with HIV | NIH: National Institute of Allergy and Infectious Diseases

NIH Study Examines How Pregnancy Affects Drugs for HIV and TB in People Living with HIV | NIH: National Institute of Allergy and Infectious Diseases

Wednesday, January 23, 2019 NIH Study Examines How Pregnancy Affects Drugs for HIV and TB in Women Living with HIV The safety and dosing requirements of a new drug licensed for use by nonpregnant adults may differ for pregnant women. This has been the case for drugs for treating both HIV and tuberculosis (TB), the most common HIV co-infection. A NIAID-supported study into how pregnancy affects the body’s processing of drugs for HIV and TB has helped provide a foundation for national and international HIV treatment guidelines for women who are pregnant or have recently given birth. The study recently enrolled its 1,001st participant, enabling investigators to build one of the world’s largest data sets of its kind.